A MODERN APPROACH TO THE TREATMENT OF ACUTE OTITIS MEDIA DEVELOPED AGAINST THE BACKGROUND OF CHRONIC VIRAL HEPATITIS B
Keywords:
chronic viral hepatitis B, acute otitis media, treatment, immuno-correlation therapyAbstract
Inflammatory diseases of the outer and middle ear, developing against the background of HBV, are characterized by the duration of the process and low effectiveness of conservative therapy.With the development of inflammatory processes of the disease, great importance should be attached to nonspecific resistance and immunological processes.
References
Abdel-Razek O., Ni L., Yang F., Wang G. Innate immunity of surfactant protein A in experimental otitis media // Innate Immun. 2019 Oct;25(7).-Р.391-400.
Anutebeh E.N., Tatah L., Feteh V.F., Aroke D., Assob J.CN, Choukem S.P. Immune response to hepatitis B vaccine following complete immunization of children attending two regional hospitals in the Southwest region of Cameroon: a cross sectional study // BMC Infect Dis. 2021 Dec 2;21(1).-Р.1205
Al-Romaihi H., Al-Masri H., Shawky S. Assessment of hepatitis B immunization programme among school students in Qatar // East Mediterr Health J. 2018 Oct 10;24(8).-Р.736-744.
Aljaberi N., Ghulam E., Smitherman EA. Maintaining Hepatitis B Protection in Immunocompromised Pediatric Rheumatology and Inflammatory Bowel Disease Patient // J Rheumatol. 2021 Aug;48(8).-Р.1314-1321.
Balaban H.Y., Aslan A.T., Ayar ŞN. Lack of awareness of Hepatitis B screening and vaccination in high-risk groups // Turk J Med Sci. 2021 Jun 28;51(3).-Р.1229-1233.
Bardou ML.D., Pontarolli D., Grumach A.S. Otitis Media and Inborn Errors of Immunity // Curr Allergy Asthma Rep. 2020 Jul 11;20(10).-Р.59.
Behzadifar M., Azari S., Shirkhani S. Hepatitis B vaccination in Iran: Historical policies and programs // J Prev Med Hyg. 2022 Dec 31;63(4).-Р.618-624.
Bhutta M.F. Evolution and Otitis Media: A Review, and a Model to Explain High Prevalence in Indigenous Populations // Hum Biol. 2015 Apr;87(2).-Р.92-108.
Bogomilsky M.R., Kulmakov S.A., Soldatsky Y.L.Osobennosti bakterial'noi mikrobioty pri ostrom gnoinom srednem otite u detei [Features of bacterial microbiota in acute purulent otitis media in children] // Vestn Otorinolaringol. 2021;86(3)-Р.4-8.
Chen Z., Guo R., Xu J., Qiu C. Immunogenicity and protective immunity against otitis media caused by pneumococcus in mice of Hib conjugate vaccine with PsaA protein carrier // Front Med. 2016 Dec;10(4).-Р.490-498.
Choi Y.H., Perez-Cuevas M.B., Kodani M. Feasibility of Hepatitis B Vaccination by Microneedle Patch: Cellular and Humoral Immunity Studies in Rhesus Macaques // J Infect Dis. 2019 Nov 6;220(12).-Р.1926-1934.
Clarke C., Bakaletz L.O., Ruiz-Guiñazú J., Borys D., Mrkvan T. Impact of protein D-containing pneumococcal conjugate vaccines on non-typeable Haemophilus influenzae acute otitis media and carriage // Expert Rev Vaccines. 2017 Jul;16(7).-Р.1-14.
Dawson R.M., Catledge C., Scott A., Pate L.B., Vereen G. Hepatitis B immunity among undergraduate nursing students: A brief report // Public Health Nurs. 2023 Jan;40(1).-Р.167-170.
